معرفی
Howard Rosen is a Lecturer in the Department of Chemical Engineering at Stanford University and a Lecturer in Management at the Stanford Graduate School of Business (GSB). He holds an M.B.A. from Stanford GSB, an M.S. in Chemical Engineering from MIT, and a B.S. in Chemical Engineering from Stanford. Rosen serves on multiple corporate boards, including as Chairman of Alcobra, Ltd. (since 2014) and as interim CEO of AcelRx, Inc. (since 2015). Previously, he held executive roles at ALZA Corporation (President, 1994–2004) and Gilead Sciences, Inc. (Vice President, Commercial Strategy, 2004–2008). He has also served as interim president/CEO of Pearl Therapeutics and is a member of the National Academy of Engineering.
- Education:
- M.B.A., Stanford Graduate School of Business
- M.S., Chemical Engineering, MIT
- B.S., Chemical Engineering, Stanford University
His professional focus spans pharmaceutical commercial strategy, corporate leadership, and interdisciplinary engineering-management education. Rosen bridges academia and industry through advisory roles, board memberships, and executive leadership in biotechnology and healthcare sectors.
- Awards:
- Member of the National Academy of Engineering
Rosen’s advisory contributions include interim executive roles at multiple pharmaceutical firms and active board participation. His academic engagement emphasizes leveraging engineering principles in business strategy and healthcare innovation.
